Literature DB >> 3716009

[Autologous blood-antibiotic filling as effective therapy of chronic osteomyelitis].

L Faupel, K Kunze, H Ecke.   

Abstract

A control of osteomyelitis by parenteral administration of antibiotic drugs is not possible due to sequestration, thrombosis of the peripheral vessels, and encapsulation of the osseous focuses. The autoblood-antibiotic plombage was indicated in 1951 by Winter. The principle used for this method is the concentration of one or more antibiotic drugs in an autogenic carrier releasing the drugs which then exert their effect directly at the site of the disease. In the experimentation on animals, the streptomycin level in the peripheral blood decreases only after 130 hours to the inhibiting threshold value of 0.008 g/ml. The autoblood-antibiotic filling becomes a connective tissue filling and, about seven weeks later, a bone filling. There are three conditions for a therapeutic success of the antibiotic plombage. 1. It must be only a limited, unilocalized, not too extended bone process. 2. large débridement and sequestrotomy, and 3. the bone must be provided with an own absolute stability. 74 out of 112 patients treated with an autoblood-antibiotic plombage were immediately free from symptoms. Two thirds of these patients showed a superficial recovery.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3716009     DOI: 10.1007/bf02588333

Source DB:  PubMed          Journal:  Unfallchirurgie        ISSN: 0340-2649


  6 in total

1.  [HISTOLOGICAL INVESTIGATIONS OF SEVERAL CASES OF CHRONIC OSTEOMYELITIS TREATED WITH AUTOLOGOUS BLOOD-ANTIBIOTIC PLOMBAGE].

Authors:  G BENEKE; H ECKE; A BIKFALVI
Journal:  Bruns Beitr Klin Chir       Date:  1964-12

2.  [The antibacterial irrigation drainage of surgical infections].

Authors:  H WILLENEGGER; W ROTH
Journal:  Dtsch Med Wochenschr       Date:  1962-07-27       Impact factor: 0.628

3.  [Treatment of chronic osteomyelitis].

Authors:  G HEINEMANN
Journal:  Chirurg       Date:  1959-01       Impact factor: 0.955

4.  [Experimental and clinical use of products prepared from bovine plasma. III. Clinical use of hemostatic fibrine products].

Authors:  L WINTER; T BENEDEK; D BAGDY
Journal:  Zentralbl Chir       Date:  1953       Impact factor: 0.942

5.  [Antibiotic obturation of osteomyelitic bone cavities with additional transplantation of Kiel bone spongiosa and antibiotic rinsing-drainage by Willenegger].

Authors:  W Axhausen; L Schweiberer
Journal:  Zentralbl Chir       Date:  1966-07-30       Impact factor: 0.942

6.  [Comparison of growth of Staphylococcus aureus in a fibrin-clotting system and in clotted blood - a quantitative investigation (author's transl)].

Authors:  G Stanek; P Bösch; P Weber
Journal:  Zentralbl Bakteriol Orig A       Date:  1978-06
  6 in total
  1 in total

1.  Chronic diaphyseal osteomyelitis of long bones refractory to conventional therapy - Benefits and risks of reaming of the femoral medullary cavity.

Authors:  H C Pape; H Zwipp; G Regel; H Maschek; H Tscherne
Journal:  Eur J Orthop Surg Traumatol       Date:  1995-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.